Advertisement ORNI signs new distribution contract with Central Business USA - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ORNI signs new distribution contract with Central Business USA

Oragenics (ORNI) has signed a new three year distribution contract with Central Business USA for Oragenics' Oral Care Probiotics for Adults, Kids and Pets in Brazil, Argentina, Paraguay and Uruguay.

All products will contain ProBiora3, the Company’s patented proprietary blend of three probiotics purposely designed for oral health.

Oragenics president and CEO John Bonfiglio said the agreement reinforces Oragenics’ strategy to continue to expand the oral probiotic product line in the international market.

"We are confident that in concert with Central Business USA, we can develop a substantial market in these four countries," Bonfiglio added.

Central Business USA provides prescription medication, medical products, vitamins and supplements to the US and South American market.